Purpose
to support Global Polio Eradication Initiative Novel Oral Polio Vaccine Type-2 (nOPV2) Working Group to facilitate nOPV2 introduction
Grantee
Division
Global Development
Date
MAY 2020
Region served
GLOBAL
Committed amount
$2,649,321
Grant topic
Polio
Duration (months)
61
Grantee location
Geneva, Genève, Switzerland
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.